|
1
|
Li L and Bhatia R: Stem cell quiescence.
Clin Cancer Res. 17:4936–4941. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pece S, Tosoni D, Confalonieri S, Mazzarol
G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG and Di Fiore
PP: Biological and molecular heterogeneity of breast cancers
correlates with their cancer stem cell content. Cell. 140:62–73.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Okumura T, Shimada Y, Imamura M and
Yasumoto S: Neurotrophin receptor p75(NTR) characterizes human
esophageal keratinocyte stem cells in vitro. Oncogene.
22:4017–4026. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Okumura T, Shimada Y, Sakurai T, Hori R,
Nagata T, Sakai Y and Tsukada K: Abnormal cell proliferation in the
p75NTR-positive basal cell compartment of the esophageal epithelium
during squamous carcinogenesis. Dis Esophagus. 28:634–643. 2015.
View Article : Google Scholar
|
|
5
|
Okumura T, Tsunoda S, Mori Y, Ito T,
Kikuchi K, Wang TC, Yasumoto S and Shimada Y: The biological role
of the low-affinity p75 neurotrophin receptor in esophageal
squamous cell carcinoma. Clin Cancer Res. 12:5096–5103. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang SD, Yuan Y, Liu XH, Gong DJ, Bai CG,
Wang F, Luo JH and Xu ZY: Self-renewal and chemotherapy resistance
of p75NTR positive cells in esophageal squamous cell carcinomas.
BMC Cancer. 9:92009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao JS, Li WJ, Ge D, Zhang PJ, Li JJ, Lu
CL, Ji XD, Guan DX, Gao H, Xu LY, et al: Tumor initiating cells in
esophageal squamous cell carcinomas express high levels of CD44.
PLoS One. 6:e214192011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang KH, Dai YD, Tong M, Chan YP, Kwan PS,
Fu L, Qin YR, Tsao SW, Lung HL, Lung ML, et al: A CD90(+)
tumor-initiating cell population with an aggressive signature and
metastatic capacity in esophageal cancer. Cancer Res. 73:2322–2332.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shimada Y, Okumura T, Sekine S, Moriyama
M, Sawada S, Matsui K, Yoshioka I, Hojo S, Yoshida T, Nagata T, et
al: Expression analysis of iPS cell - inductive genes in esophageal
squamous cell carcinoma by tissue microarray. Anticancer Res.
32:5507–5514. 2012.PubMed/NCBI
|
|
10
|
Shimada Y, Imamura M, Wagata T, Yamaguchi
N and Tobe T: Characterization of 21 newly established esophageal
cancer cell lines. Cancer. 69:277–284. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sekine S, Shimada Y, Nagata T, Moriyama M,
Omura T, Yoshioka I, Hori R, Matsui K, Sawada S, Okumura T, et al:
Establishment and characterization of a new human gallbladder
carcinoma cell line. Anticancer Res. 32:3211–3218. 2012.PubMed/NCBI
|
|
12
|
Dick JE: Stem cell concepts renew cancer
research. Blood. 112:4793–4807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liotta F, Querci V, Mannelli G,
Santarlasci V, Maggi L, Capone M, Rossi MC, Mazzoni A, Cosmi L,
Romagnani S, et al: Mesenchymal stem cells are enriched in head
neck squamous cell carcinoma, correlates with tumour size and
inhibit T-cell proliferation. Br J Cancer. 112:745–754. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chung MT, Liu C, Hyun JS, Lo DD, Montoro
DT, Hasegawa M, Li S, Sorkin M, Rennert R, Keeney M, et al: CD90
(Thy-1)-positive selection enhances osteogenic capacity of human
adipose-derived stromal cells. Tissue Eng Part A. 19:989–997. 2013.
View Article : Google Scholar :
|
|
15
|
Haeryfar SMM and Hoskin DW: Thy-1: More
than a mouse pan-T cell marker. J Immunol. 173:3581–3588. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsunoda S, Okumura T, Ito T, Mori Y, Soma
T, Watanabe G, Kaganoi J, Itami A, Sakai Y and Shimada Y:
Significance of nerve growth factor overexpression and its
autocrine loop in oesophageal squamous cell carcinoma. Br J Cancer.
95:322–330. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roesch A, Fukunaga-Kalabis M, Schmidt EC,
Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T
and Herlyn M: A temporarily distinct subpopulation of slow-cycling
melanoma cells is required for continuous tumor growth. Cell.
141:583–594. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao MQ, Choi YP, Kang S, Youn JH and Cho
NH: CD24+ cells from hierarchically organized ovarian
cancer are enriched in cancer stem cells. Oncogene. 29:2672–2680.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dembinski JL and Krauss S:
Characterization and functional analysis of a slow cycling stem
cell-like subpopulation in pancreas adenocarcinoma. Clin Exp
Metastasis. 26:611–623. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mani SA, Guo W, Liao M-J, Eaton EN,
Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et
al: The epithelial-mesenchymal transition generates cells with
properties of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roeder I, Horn M, Glauche I, Hochhaus A,
Mueller MC and Loeffler M: Dynamic modeling of imatinib-treated
chronic myeloid leukemia: Functional insights and clinical
implications. Nat Med. 12:1181–1184. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang B, Strauss AC, Chu S, Li M, Ho Y,
Shiang KD, Snyder DS, Huettner CS, Shultz L, Holyoake T, et al:
Effective targeting of quiescent chronic myelogenous leukemia stem
cells by histone deacetylase inhibitors in combination with
imatinib mesylate. Cancer Cell. 17:427–442. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tomellini E, Touil Y, Lagadec C, Julien S,
Ostyn P, Ziental-Gelus N, Meignan S, Lengrand J, Adriaenssens E,
Polakowska R, et al: Nerve growth factor and proNGF simultaneously
promote symmetric self-renewal, quiescence, and epithelial to
mesenchymal transition to enlarge the breast cancer stem cell
compartment. Stem Cells. 33:342–353. 2015. View Article : Google Scholar
|
|
24
|
Wilson A, Laurenti E, Oser G, van der Wath
RC, Blanco-Bose W, Jaworski M, Offner S, Dunant CF, Eshkind L,
Bockamp E, et al: Hematopoietic stem cells reversibly switch from
dormancy to self-renewal during homeostasis and repair. Cell.
135:1118–1129. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Buczacki S, Davies RJ and Winton DJ: Stem
cells, quiescence and rectal carcinoma: An unexplored relationship
and potential therapeutic target. Br J Cancer. 105:1253–1259. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chaffer CL, Marjanovic ND, Lee T, Bell G,
Kleer CG, Reinhardt F, D'Alessio AC, Young RA and Weinberg RA:
Poised chromatin at the ZEB1 promoter enables breast cancer cell
plasticity and enhances tumorigenicity. Cell. 154:61–74. 2013.
View Article : Google Scholar : PubMed/NCBI
|
